AGVHX | CWICX | AGVHX / CWICX | |
Total Expense Ratio | 0.45 | 1.53 | 29% |
Annual Report Gross Expense Ratio | 0.45 | 1.53 | 29% |
Fund Existence | 14 years | 24 years | - |
Gain YTD | 16.375 | 15.585 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.1B | 137B | 13% |
Annual Yield % from dividends | 1.10 | 0.77 | 144% |
Returns for 1 year | 16.86 | 12.28 | 137% |
Returns for 3 years | 60.10 | 52.00 | 116% |
Returns for 5 years | 63.82 | 45.28 | 141% |
Returns for 10 years | 133.09 | 84.13 | 158% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MRNY | 1.81 | 0.04 | +2.26% |
YieldMax MRNA Option Income Strategy ETF | |||
HEAL | 32.00 | 0.27 | +0.84% |
Global X HealthTech ETF | |||
MAYZ | 32.69 | 0.15 | +0.46% |
TrueShares Structured Outcome May ETF | |||
GVUS | 51.76 | -0.13 | -0.24% |
Goldman Sachs MktBt Russell LgCpValEqETF | |||
FXO | 58.87 | -0.88 | -1.47% |
First Trust Financials AlphaDEX® ETF |